CLINSQUARE: CLINICAL RESEARCH COURSES
Tuesday, January 14, 2025
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
HomeAuthorsPosts by admin

admin

admin
1861 POSTS6 COMMENTS
Latest Pharma-News

FDA approves Tazverik (tazemetostat) for the treatment of adults and pediatric patients with metastatic or locally advanced epithelioid sarcoma

admin - 0
Latest Pharma-News

Celularity Announces FDA Clearance of IND for CYNK-001, an Allogeneic, Off-the-Shelf Cryopreserved NK Cell Therapy for glioblastoma multiforme (GBM)

admin - 0
Latest Pharma-News

FDA Approves Medtronic Micra™ AV, the World’s Smallest Pacemaker with atrioventricular (AV) synchrony for the treatment of patients with AV block

admin - 0
Latest Pharma-News

Akcea and Ionis report positive topline Phase 2 results of AKCEA-APOCIII-L Rx for the treatment of hypertriglyceridemia

admin - 0
Latest Pharma-News

European Commission approves Darzalex® in combination with bortezomib, thalidomide and dexamethasone for multiple myeloma

admin - 0
Latest Pharma-News

Jazz Pharmaceuticals reported that EU Marketing Authorisation for Sunosi® (solriamfetol) for Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea

admin - 0
Latest Pharma-News

AstraZeneca’s ‘Desire Zero Carbon’ system to take out outflows by 2025 and be carbon negative over the whole worth chain by 2030

admin - 0
Latest Pharma-News

Free “LabXchange” Science Education Accelerator Launched By the Amgen Foundation And Faculty of Arts and Sciences at Harvard

admin - 0
Latest Pharma-News

US FDA grants priority review of GlaxoSmithKline’s belantamab mafodotin for patients with relapsed or refractory multiple myeloma

admin - 0
Latest Pharma-News

The U.S.FDA approved Horizon Therapeutics Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye disease

admin - 0
Latest Pharma-News

Supernus Announces U.S. FDA Acceptance for Review of the New Drug Application for SPN-812 for the Treatment of ADHD

admin - 0
Latest Pharma-News

The European Commission (EC) approved Novartis Mayzent® (siponimod) for adult patients with secondary progressive multiple sclerosis (SPMS) with active disease

admin - 0
1...140141142...156Page 141 of 156

TOP AUTHORS

admin
admin
1861 POSTS6 COMMENTS
OIdMIHuOdiu
OIdMIHuOdiu
0 POSTS0 COMMENTS
tintin
tintin
0 POSTS0 COMMENTS
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved